Dan Lunn

Dan Lunn is a Principal Scientist at Gilead Sciences since September 2023, bringing extensive experience from previous roles at Vertex Pharmaceuticals, where Lunn served as a Senior Manager and Chromatography Team Lead from January 2018 to September 2023. In this position, Lunn led a team of seven scientists in liquid chromatography method development and validation for small molecule clinical programs, overseeing methods crucial for drug substance and product testing. Prior to this, Lunn held roles as a Senior Scientist and Scientist, contributing to the development of methods for clinical programs and NDA filings. Lunn's background includes a Ph.D. in Chemistry from the University of North Carolina at Chapel Hill, where research focused on diffusion properties and chromatography, as well as an undergraduate degree in Chemistry from Luther College, where early work involved separation methods for natural compounds.